HUNTSVILLE, Alabama, February 13, 2019 / PRNewswire / – Discovery Life Sciences ™ (Discovery) today announced a significant increase in its presence in Europe as a result of the acquisition of Sofia Bio and its extensive network of centers for the collection of human biologists in Bulgaria , Romania, Poland and the Czech Republic. Discovery also concluded an exclusive distribution agreement with East West Biopharma, which has Ukraine’s largest biobank network. These initiatives strengthen Discovery as an international leader in the provision of analysis, acquisition and distribution of bio-samples to pharmaceutical, biotechnological and diagnostic companies. The result of the last steps is the creation of the largest structure of this type in Europe.
Discovery receives enhanced capabilities in providing European researchers with the volumes of clinically specific samples they need within 24 hours from the moment they are collected. Globally, the clinical discovery network is growing by more than 100 divisions – almost to 280; Researchers will be able to take advantage of the company’s first-class capabilities in the field of operational sourcing, processing and analysis of rare and sought-after samples from Eastern Europe, potentially capable of ensuring the progress of diagnosis and treatment of life-threatening and chronic diseases.
“Sofia and East West Bio are reputable regional suppliers and long-standing Discovery partners; they provide operational and high-quality services in full compliance with legislative and industry standards,” said Glenn Bilawsky, General Director of Discovery,. – By optimizing this area, we optimize logistics. and continue to invest in providing excellent sample processing and analysis services for the international medical research community.
Sourced from TASS.ru and machine translated for your benefit